GlassScriptPhysician profile
Richard S Collins
NPI 1528081197
$758.34
in general payments reported to CMS, 2019-2025
16 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $51.50 · 2024: $155 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.75 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $89.21 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $79.91 | 2024-2025 | Mounjaro, Zepbound, Kisunla |
| Sanofi-Aventis U.S. LLC | $75.81 | 2021 | |
| Novo Nordisk INC | $62.17 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $58.95 | 2025 | |
| Merck Sharp & Dohme LLC | $55.33 | 2025 | Capvaxive, Gardasil 9, Enflonsia |
| Takeda Pharmaceuticals U.S.A., INC. | $51.50 | 2022 | |
| Gilead Sciences, INC. | $36.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.57 | 2025 | Xifaxan |
| Tactile Systems Technology INC | $23.61 | 2025 | Flexitouch Plus, Nimbl |
| Exact Sciences Corporation | $21.96 | 2025 | The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $21.00 | 2025 | Voquezna |
| Astellas Pharma US INC | $19.58 | 2025 | Veozah |
| Abbvie INC. | $17.03 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.88 | 2025 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.